ATF6B
Basic information
Region (hg38): 6:32115264-32128253
Previous symbols: [ "CREBL1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ATF6B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 30 | 36 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 30 | 7 | 0 |
Variants in ATF6B
This is a list of pathogenic ClinVar variants found in the ATF6B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-32115764-T-A | not specified | Uncertain significance (Jan 26, 2022) | ||
6-32115791-G-T | not specified | Uncertain significance (Nov 18, 2022) | ||
6-32115953-C-T | not specified | Uncertain significance (Jun 02, 2023) | ||
6-32116560-T-A | Likely benign (May 21, 2018) | |||
6-32116738-C-T | not specified | Uncertain significance (Sep 28, 2022) | ||
6-32116741-C-T | not specified | Uncertain significance (Dec 06, 2021) | ||
6-32116787-G-A | not specified | Uncertain significance (Nov 08, 2022) | ||
6-32117095-G-A | not specified | Likely benign (Apr 05, 2023) | ||
6-32117315-C-T | Benign (Jul 10, 2018) | |||
6-32117378-A-G | not specified | Uncertain significance (Jan 11, 2023) | ||
6-32117394-C-T | not specified | Uncertain significance (Apr 27, 2023) | ||
6-32117886-G-A | not specified | Likely benign (Jan 04, 2022) | ||
6-32117916-C-T | not specified | Likely benign (Oct 03, 2023) | ||
6-32117920-G-T | not specified | Uncertain significance (Jan 18, 2022) | ||
6-32117932-C-T | not specified | Uncertain significance (Jun 11, 2021) | ||
6-32117965-G-C | not specified | Uncertain significance (Feb 10, 2023) | ||
6-32118018-G-A | not specified | Uncertain significance (Oct 04, 2022) | ||
6-32118034-T-C | not specified | Uncertain significance (Jul 05, 2023) | ||
6-32118978-C-T | not specified | Likely benign (May 24, 2024) | ||
6-32119101-C-T | not specified | Uncertain significance (May 30, 2023) | ||
6-32119832-C-G | not specified | Uncertain significance (Feb 15, 2023) | ||
6-32119871-T-G | not specified | Uncertain significance (Apr 18, 2023) | ||
6-32119911-T-G | not specified | Uncertain significance (Apr 05, 2023) | ||
6-32120879-G-A | not specified | Uncertain significance (May 13, 2022) | ||
6-32120885-G-A | not specified | Uncertain significance (Apr 09, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ATF6B | protein_coding | protein_coding | ENST00000375203 | 18 | 30078 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.10e-7 | 0.999 | 125711 | 0 | 36 | 125747 | 0.000143 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.53 | 315 | 401 | 0.785 | 0.0000217 | 4489 |
Missense in Polyphen | 120 | 157.78 | 0.76056 | 1779 | ||
Synonymous | 1.32 | 144 | 166 | 0.870 | 0.00000870 | 1522 |
Loss of Function | 2.98 | 17 | 36.4 | 0.466 | 0.00000188 | 397 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000145 | 0.000145 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000326 | 0.000326 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000172 | 0.000158 |
Middle Eastern | 0.000326 | 0.000326 |
South Asian | 0.000164 | 0.000163 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional factor that acts in the unfolded protein response (UPR) pathway by activating UPR target genes induced during ER stress. Binds DNA on the 5'-CCAC[GA]-3' half of the ER stress response element (ERSE) (5'-CCAATN(9)CCAC[GA]-3') when NF-Y is bound to ERSE.;
- Pathway
- PI3K-Akt signaling pathway - Homo sapiens (human);Cortisol synthesis and secretion - Homo sapiens (human);Relaxin signaling pathway - Homo sapiens (human);Aldosterone synthesis and secretion - Homo sapiens (human);Dopaminergic synapse - Homo sapiens (human);Cushing,s syndrome - Homo sapiens (human);Thyroid hormone synthesis - Homo sapiens (human);Protein processing in endoplasmic reticulum - Homo sapiens (human);TNF signaling pathway - Homo sapiens (human);Adrenergic signaling in cardiomyocytes - Homo sapiens (human);Longevity regulating pathway - Homo sapiens (human);Estrogen signaling pathway - Homo sapiens (human);Amphetamine addiction - Homo sapiens (human);Viral carcinogenesis - Homo sapiens (human);Hepatitis B - Homo sapiens (human);cGMP-PKG signaling pathway - Homo sapiens (human);Alcoholism - Homo sapiens (human);Cocaine addiction - Homo sapiens (human);Insulin secretion - Homo sapiens (human);Myometrial Relaxation and Contraction Pathways;Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;PI3K-Akt Signaling Pathway;G1 to S cell cycle control
(Consensus)
Intolerance Scores
- loftool
- 0.858
- rvis_EVS
- 0.13
- rvis_percentile_EVS
- 63.57
Haploinsufficiency Scores
- pHI
- 0.218
- hipred
- Y
- hipred_score
- 0.520
- ghis
- 0.504
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.824
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Atf6b
- Phenotype
- cellular phenotype; hearing/vestibular/ear phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- transcription, DNA-templated;signal transduction;ATF6-mediated unfolded protein response;positive regulation of transcription by RNA polymerase II;negative regulation of ATF6-mediated unfolded protein response;positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress
- Cellular component
- nucleus;nucleolus;endoplasmic reticulum membrane;Golgi apparatus;integral component of endoplasmic reticulum membrane;protein-DNA complex;RNA polymerase II transcription factor complex
- Molecular function
- RNA polymerase II distal enhancer sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA-binding transcription factor activity;protein binding;cAMP response element binding;transcription regulatory region DNA binding